Polianta LTD Bristol Myers Squibb CO Transaction History

Polianta LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 Apr 07, 2020	SELL	$46.4 - $67.43 $909,440 - $1.32 Million	-19,600 Closed	0 $0
Q4 2019 Jan 13, 2020	SELL	$49.21 - $64.19 $280,497 - $365,883	-5,700 Reduced 22.53%	19,600 $1.26 Million
Q3 2019 Oct 09, 2019	BUY	$42.77 - $50.71 $1.08 Million - $1.28 Million	25,300 New	25,300 $1.28 Million
Q4 2018 Jan 15, 2019	SELL	$48.76 - $63.23 $1.01 Million - $1.31 Million	-20,700 Closed	0 $0
Q3 2018 Oct 15, 2018	BUY	$55.19 - $62.25 $1.14 Million - $1.29 Million	20,700 New	20,700 $1.29 Million

2,428

1.5B

29.7M

32.2M

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $113B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

Get notified when there are updates to the investment portfolio of Polianta LTD, based on Form 13F filings with the SEC.

Stay updated on Polianta LTD with notifications on news.